Arrowstreet Capital’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-47,849
| Closed | -$164K | – | 2406 |
|
|
2020
Q4 | $164K | Sell |
47,849
-1,055,858
| -96% | -$3.62M | ﹤0.01% | 2198 |
|
|
2020
Q3 | $1.59M | Buy |
1,103,707
+333,486
| +43% | +$480K | ﹤0.01% | 1659 |
|
|
2020
Q2 | $1.54M | Buy |
770,221
+22,552
| +3% | +$45K | ﹤0.01% | 1590 |
|
|
2020
Q1 | $1.46M | Buy |
747,669
+55,066
| +8% | +$107K | ﹤0.01% | 1176 |
|
|
2019
Q4 | $2.87M | Buy |
+692,603
| New | +$2.87M | 0.01% | 1024 |
|
|
2017
Q2 | – | Sell |
-514,658
| Closed | -$7.38M | – | 1219 |
|
|
2017
Q1 | $7.38M | Buy |
+514,658
| New | +$7.38M | 0.03% | 467 |
|
|
2016
Q4 | – | Sell |
-944,704
| Closed | -$17.1M | – | 2164 |
|
|
2016
Q3 | $17.1M | Buy |
944,704
+739,291
| +360% | +$13.4M | 0.06% | 332 |
|
|
2016
Q2 | $2.95M | Buy |
+205,413
| New | +$2.95M | 0.01% | 731 |
|
|
2016
Q1 | – | Sell |
-102,219
| Closed | -$1.36M | – | 1442 |
|
|
2015
Q4 | $1.36M | Buy |
+102,219
| New | +$1.36M | 0.01% | 904 |
|
|
2015
Q3 | – | Sell |
-62,745
| Closed | -$505K | – | 1433 |
|
|
2015
Q2 | $505K | Buy |
+62,745
| New | +$505K | ﹤0.01% | 978 |
|